< Back to companies
NeuroKaire

NeuroKaire

Jerusalem, Israel

Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2018
Website
www.neurokaire.com/

Categories

Depression

Disease Areas

Technologies

PharmacogenomicsPredictive AnalyticsBiomarkers
Only accessible to MedStartr community members. Join now

What do you think of NeuroKaire?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now